Feature Essay How moves towards universal health coverage could encourage poor quality drugs: an essay by Elizabeth Pisani BMJ 2019; 366 doi: https://doi.org/10.1136/bmj.l5327 (Published 04 September 2019) Cite this as: BMJ 2019;366:l5327 Read our Universal Health Coverage collection Article Related content Metrics Responses Peer review Related articles Letter Universal health coverage: drug quality and affordability can go together Published: 15 October 2019; BMJ 367 doi:10.1136/bmj.l6004 See more Covid-19: Is the UK heading towards mandatory vaccination of healthcare workers? BMJ April 21, 2021, 373 n1056; DOI: https://doi.org/10.1136/bmj.n1056 Invest to staff the NHS properly, healthcare leaders warn prime minister BMJ April 21, 2021, 373 n1059; DOI: https://doi.org/10.1136/bmj.n1059 Discussion of DNACPR processes in medical education would improve practice BMJ April 21, 2021, 373 n1045; DOI: https://doi.org/10.1136/bmj.n1045 Covid-19: Canada relaxes age limits on AstraZeneca vaccine as Ontario cases surge BMJ April 21, 2021, 373 n1053; DOI: https://doi.org/10.1136/bmj.n1053 Covid-19: Unusual blood clots are “very rare side effect” of Janssen vaccine, says EMA BMJ April 21, 2021, 373 n1046; DOI: https://doi.org/10.1136/bmj.n1046 Cited by... Universal health coverage: drug quality and affordability can go togetherFulltext PDF
